The term LOC644192 Inhibitors defines a specialized class of chemical compounds meticulously designed to modulate the activity of LOC644192, a molecular target currently under scientific investigation. These inhibitors are intricately crafted through principles rooted in medicinal chemistry, with a primary focus on selectively interfering with the normal functions of LOC644192 within cellular processes. The structural features of LOC644192 Inhibitors undergo a rigorous optimization process, often involving computational modeling and structure-activity relationship studies, to refine their molecular configurations for precise binding to the target.
The significance of LOC644192 Inhibitors lies in their potential to disrupt the biochemical activities associated with LOC644192, a molecular entity believed to play a role in various biological pathways. Researchers in this field delve into the three-dimensional structure of LOC644192 and its binding interactions with inhibitors, aiming to unravel the intricate molecular mechanisms underlying inhibition. The study of LOC644192 Inhibitors contributes to a broader understanding of cellular processes, offering insights into the roles played by LOC644192 in diverse biological pathways and expanding our knowledge of the regulatory networks governing cellular activities. This research not only advances our comprehension of the molecular intricacies surrounding LOC644192 but also contributes to the broader scientific understanding of molecular targets and their involvement in fundamental cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates into DNA and can inhibit RNA polymerase, potentially decreasing lncRNA transcription. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone intercalates into DNA and inhibits Topoisomerase II, potentially affecting RNA transcription. | ||||||
Pixantrone | 144510-96-3 | sc-481154 | 5 mg | $615.00 | ||
Pixantrone is a DNA-intercalating agent with actions similar to anthracyclines and could inhibit lncRNA transcription. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
It inhibits protein synthesis at the level of translation initiation and may indirectly affect lncRNA expression. | ||||||
BMH-21 | 896705-16-1 | sc-507460 | 10 mg | $165.00 | ||
BMH-21 binds to RNA polymerase I, leading to its degradation, which could decrease the transcription of certain lncRNAs. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
CX-5461 selectively inhibits RNA Polymerase I, potentially reducing the transcription of some lncRNAs. | ||||||
Acridine Orange solution | 65-61-2 | sc-473594 | 10 ml | $166.00 | 2 | |
Acridine Orange intercalates into nucleic acids and can inhibit macromolecular biosynthesis. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA, inhibiting RNA polymerase and thus transcription, potentially reducing lncRNA levels. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bisantrene is a DNA intercalating agent that could disrupt transcription processes, affecting lncRNA synthesis. | ||||||